guest ::
| Home > Publications Database > Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data. > print |
| Home > Publications Database > Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data. > print |
| 001 | 138797 | ||
| 005 | 20240321220511.0 | ||
| 024 | 7 | _ | |a 10.3233/JAD-151006 |2 doi |
| 024 | 7 | _ | |a pmid:27567804 |2 pmid |
| 024 | 7 | _ | |a 1387-2877 |2 ISSN |
| 024 | 7 | _ | |a 1875-8908 |2 ISSN |
| 024 | 7 | _ | |a altmetric:11232811 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-05119 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Gomm, Willy |0 P:(DE-2719)2811376 |b 0 |e First author |u dzne |
| 245 | _ | _ | |a Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data. |
| 260 | _ | _ | |a Amsterdam |c 2016 |b IOS Press |
| 264 | _ | 1 | |3 print |2 Crossref |b IOS Press |c 2016-09-06 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1710940968_2065 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a While acute detrimental effects of benzodiazepine (BDZ), and BDZ and related z-substance (BDZR) use on cognition and memory are known, the association of BDZR use and risk of dementia in the elderly is controversially discussed. Previous studies on cohort or claims data mostly show an increased risk for dementia with the use of BDZs or BDZRs. For Germany, analyses on large population-based data sets are missing.To evaluate the association between regular BDZR use and incident any dementia in a large German claims data set.Using longitudinal German public health insurance data from 2004 to 2011 we analyzed the association between regular BDZR use (versus no BDZR use) and incident dementia in a case-control design. We examined patient samples aged≥60 years that were free of dementia at baseline. To address potential protopathic bias we introduced a lag time between BDZR prescription and dementia diagnosis. Odds ratios were calculated applying conditional logistic regression, adjusted for potential confounding factors such as comorbidities and polypharmacy.The regular use of BDZRs was associated with a significant increased risk of incident dementia for patients aged≥60 years (adjusted odds ratio [OR] 1.21, 95% confidence interval [CI] 1.13-1.29). The association was slightly stronger for long-acting substances than for short-acting ones. A trend for increased risk for dementia with higher exposure was observed.The restricted use of BDZRs may contribute to dementia prevention in the elderly. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 536 | _ | _ | |a 345 - Population Studies and Genetics (POF3-345) |0 G:(DE-HGF)POF3-345 |c POF3-345 |f POF III |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Benzodiazepines |0 12794-10-4 |2 NLM Chemicals |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 650 | _ | 2 | |a Aged, 80 and over |2 MeSH |
| 650 | _ | 2 | |a Benzodiazepines: adverse effects |2 MeSH |
| 650 | _ | 2 | |a Benzodiazepines: chemistry |2 MeSH |
| 650 | _ | 2 | |a Case-Control Studies |2 MeSH |
| 650 | _ | 2 | |a Dementia: chemically induced |2 MeSH |
| 650 | _ | 2 | |a Dementia: diagnosis |2 MeSH |
| 650 | _ | 2 | |a Dementia: epidemiology |2 MeSH |
| 650 | _ | 2 | |a Drug Utilization: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Drug Utilization: trends |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Follow-Up Studies |2 MeSH |
| 650 | _ | 2 | |a Germany: epidemiology |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Insurance Claim Reporting: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Insurance Claim Reporting: trends |2 MeSH |
| 650 | _ | 2 | |a Longitudinal Studies |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 650 | _ | 2 | |a Risk Factors |2 MeSH |
| 700 | 1 | _ | |a von Holt, Klaus |0 P:(DE-2719)2810710 |b 1 |u dzne |
| 700 | 1 | _ | |a Thomé, Friederike |0 P:(DE-2719)2810705 |b 2 |u dzne |
| 700 | 1 | _ | |a Broich, Karl |b 3 |
| 700 | 1 | _ | |a Maier, Wolfgang |0 P:(DE-2719)2000015 |b 4 |u dzne |
| 700 | 1 | _ | |a Weckbecker, Klaus |b 5 |
| 700 | 1 | _ | |a Fink, Anne |0 P:(DE-2719)2241493 |b 6 |u dzne |
| 700 | 1 | _ | |a Doblhammer-Reiter, Gabriele |0 P:(DE-2719)2811246 |b 7 |u dzne |
| 700 | 1 | _ | |a Haenisch, Britta |0 P:(DE-2719)2810511 |b 8 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.3233/jad-151006 |b : IOS Press, 2016-09-06 |n 2 |p 801-808 |3 journal-article |2 Crossref |t Journal of Alzheimer's Disease |v 54 |y 2016 |x 1387-2877 |
| 773 | _ | _ | |a 10.3233/JAD-151006 |g Vol. 54, no. 2, p. 801 - 808 |0 PERI:(DE-600)2070772-1 |n 2 |q 54:2<801 - 808 |p 801-808 |t Journal of Alzheimer's disease |v 54 |y 2016 |x 1387-2877 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/138797/files/DZNE-2020-05119_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/138797/files/DZNE-2020-05119_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:138797 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2811376 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2810710 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2810705 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2000015 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)2241493 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2811246 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)2810511 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-345 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Population Studies and Genetics |x 1 |
| 914 | 1 | _ | |y 2016 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J ALZHEIMERS DIS : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-2719)1013010 |k AG Hänisch |l Pharmacoepidemiology |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)7000001 |k U Clinical Researchers - Bonn |l U Clinical Researchers - Bonn |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1012002 |k AG Doblhammer |l Demographic Studies |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1013010 |
| 980 | _ | _ | |a I:(DE-2719)7000001 |
| 980 | _ | _ | |a I:(DE-2719)1012002 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |y 2015 |2 Crossref |o Janhsen 2015 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/jgs.13666 |2 Crossref |o 10.1111/jgs.13666 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/978-3-662-43487-1 |2 Crossref |o 10.1007/978-3-662-43487-1 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1080/13803395.2014.928268 |2 Crossref |o 10.1080/13803395.2014.928268 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.2174/1381612023396654 |2 Crossref |o 10.2174/1381612023396654 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1517/14740338.2015.1014796 |2 Crossref |o 10.1517/14740338.2015.1014796 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1017/S2045796013000358 |2 Crossref |o 10.1017/S2045796013000358 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1017/S0033291704003897 |2 Crossref |o 10.1017/S0033291704003897 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/00002093-199803000-00002 |2 Crossref |o 10.1097/00002093-199803000-00002 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s40264-015-0319-3 |2 Crossref |o 10.1007/s40264-015-0319-3 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/JGP.0b013e3181a65210 |2 Crossref |o 10.1097/JGP.0b013e3181a65210 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/JGP.0b013e3181e049ca |2 Crossref |o 10.1097/JGP.0b013e3181e049ca |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/bmj.e6231 |2 Crossref |o 10.1136/bmj.e6231 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/bmj.g5205 |2 Crossref |o 10.1136/bmj.g5205 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.euroneuro.2012.05.004 |2 Crossref |o 10.1016/j.euroneuro.2012.05.004 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1371/journal.pone.0127836 |2 Crossref |o 10.1371/journal.pone.0127836 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/s13195-015-0146-x |2 Crossref |o 10.1186/s13195-015-0146-x |
| 999 | C | 5 | |y 2014 |2 Crossref |t Health among the elderly in Germany: New evidence on disease, disability and care need |o Fink Health among the elderly in Germany: New evidence on disease, disability and care need 2014 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/YIC.0b013e328344c600 |2 Crossref |o 10.1097/YIC.0b013e328344c600 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3233/JAD-150630 |2 Crossref |o 10.3233/JAD-150630 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S0895-4356(01)00453-X |2 Crossref |o 10.1016/S0895-4356(01)00453-X |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jech-2011-200314 |2 Crossref |o 10.1136/jech-2011-200314 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/bmj.i90 |2 Crossref |o 10.1136/bmj.i90 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jalz.2014.02.006 |2 Crossref |o 10.1016/j.jalz.2014.02.006 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S0960-894X(02)00909-5 |2 Crossref |o 10.1016/S0960-894X(02)00909-5 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.2174/156802611795860942 |2 Crossref |o 10.2174/156802611795860942 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nm.3639 |2 Crossref |o 10.1038/nm.3639 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s40263-015-0305-4 |2 Crossref |o 10.1007/s40263-015-0305-4 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|